Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 14, 2016

Total Value ($000): $1,721,541 (100.0% shares, 0.0% debt)

Holdings (42)

ABIOMED INC 14.1%
Value ($000) $242,294 Shares 1,884,384 Est. Cost $29.48 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 12.1%
Value ($000) $208,229 Shares 1,763,458 Est. Cost $85.99 Unrealized +39.7%
BMRN BIOMARIN PHARMACEUTICAL INC 9.6%
Value ($000) $165,694 Shares 1,790,899 Est. Cost $76.38 Unrealized +23.3%
CLOVIS ONCOLOGY INC 8.0%
Value ($000) $137,137 Shares 3,804,088 Est. Cost $53.87 Unrealized
AMAG PHARMACEUTICALS INC 4.7%
Value ($000) $81,538 Shares 3,326,720 Est. Cost $29.94 Unrealized
INSM INSMED INC 4.3%
Value ($000) $73,926 Shares 5,091,298 Est. Cost $14.63 Unrealized -14.4%
CEMPRA INC 4.0%
Value ($000) $68,836 Shares 2,844,483 Est. Cost $22.71 Unrealized
ALEXION PHARMACEUTICALS INC 4.0%
Value ($000) $68,831 Shares 561,700 Est. Cost $119.05 Unrealized
VNDA VANDA PHARMACEUTICALS INC 4.0%
Value ($000) $68,402 Shares 4,110,708 Est. Cost $8.54 Unrealized +57.7%
WRIGHT MED GROUP N V 3.5%
Value ($000) $59,865 Shares 2,440,493 Est. Cost $23.40 Unrealized
PRTA PROTHENA CORP PLC 3.3%
Value ($000) $56,039 Shares 934,455 Est. Cost $29.22 Unrealized +83.6%
ZELTIQ AESTHETICS INC 3.2%
Value ($000) $55,479 Shares 1,414,563 Est. Cost $27.05 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 2.7%
Value ($000) $47,140 Shares 1,481,930 Est. Cost $29.67 Unrealized +14.3%
FOLD AMICUS THERAPEUTICS INC 2.4%
Value ($000) $42,072 Shares 5,685,388 Est. Cost $6.12 Unrealized +10.3%
SAGE THERAPEUTICS INC 2.4%
Value ($000) $41,539 Shares 902,051 Est. Cost $38.68 Unrealized
ARIAD PHARMACEUTICALS INC 2.1%
Value ($000) $35,424 Shares 2,587,617 Est. Cost $7.02 Unrealized
CELGENE CORP 1.8%
Value ($000) $30,596 Shares 292,700 Est. Cost $97.51 Unrealized
STAA STAAR SURGICAL CO 1.8%
Value ($000) $30,499 Shares 3,244,610 Est. Cost $7.82 Unrealized +2.7%
KARYOPHARM THERAPEUTICS INC 1.7%
Value ($000) $30,025 Shares 3,085,849 Est. Cost $20.75 Unrealized
EPIZYME INC 1.6%
Value ($000) $27,695 Shares 2,814,540 Est. Cost $13.55 Unrealized
GILD GILEAD SCIENCES INC 1.5%
Value ($000) $25,192 Shares 318,400 Est. Cost $63.20 Unrealized -8.6%
SHIRE PLC 1.4%
Value ($000) $23,884 Shares 123,200 Est. Cost $221.47 Unrealized
MOMENTA PHARMACEUTICALS INC 1.1%
Value ($000) $19,299 Shares 1,650,876 Est. Cost $14.05 Unrealized
ENDO INTL PLC 1.1%
Value ($000) $19,048 Shares 945,330 Est. Cost $78.87 Unrealized
RIGEL PHARMACEUTICALS INC 1.1%
Value ($000) $19,033 Shares 5,186,088 Est. Cost $3.39 Unrealized
EXAS EXACT SCIENCES CORP 0.4%
Value ($000) $7,372 Shares 396,976 Est. Cost $12.83 Unrealized +37.3%
ACELRX PHARMACEUTICALS INC 0.4%
Value ($000) $6,359 Shares 1,634,608 Est. Cost $5.54 Unrealized
AIMMUNE THERAPEUTICS INC 0.3%
Value ($000) $5,696 Shares 379,727 Est. Cost $23.85 Unrealized
SUNESIS PHARMACEUTICALS INC 0.3%
Value ($000) $5,080 Shares 1,162,473 Est. Cost $4.37 Unrealized
ALIMERA SCIENCES INC 0.3%
Value ($000) $4,491 Shares 3,013,793 Est. Cost $4.88 Unrealized
ALGN ALIGN TECHNOLOGY INC 0.2%
Value ($000) $3,512 Shares 37,457 Est. Cost $59.75 Unrealized +51.4%
IDERA PHARMACEUTICALS INC 0.2%
Value ($000) $3,220 Shares 1,257,748 Est. Cost $3.70 Unrealized
DICERNA PHARMACEUTICALS INC 0.1%
Value ($000) $1,575 Shares 267,890 Est. Cost $9.72 Unrealized
HISTOGENICS CORP 0.1%
Value ($000) $1,459 Shares 454,545 Est. Cost $11.00 Unrealized
INTREXON CORP 0.1%
Value ($000) $1,320 Shares 47,100 Est. Cost $28.82 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value ($000) $1,135 Shares 123,686 Est. Cost $6.71 Unrealized +55.5%
SOPHIRIS BIO INC 0.0%
Value ($000) $768 Shares 247,000 Est. Cost $2.60 Unrealized
ALCOBRA LTD 0.0%
Value ($000) $674 Shares 272,788 Est. Cost $5.98 Unrealized
OREXIGEN THERAPEUTICS INC 0.0%
Value ($000) $555 Shares 167,302 Est. Cost $3.32 Unrealized
ZOGENIX INC 0.0%
Value ($000) $337 Shares 29,500 Est. Cost $13.36 Unrealized
QURE UNIQURE NV 0.0%
Value ($000) $156 Shares 20,453 Est. Cost $26.34 Unrealized -69.9%
MARINUS PHARMACEUTICALS INC 0.0%
Value ($000) $116 Shares 63,517 Est. Cost $7.84 Unrealized